A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.

NCT01197508 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

696

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: TC-5214
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]